Lipoma HMGIC fusion partner-like 1 protein (LHFPL1) is a protein encoded by the LHFPL1 gene in humans . The LHFPL1 gene is part of the lipoma HMGIC fusion partner (LHFP) gene family, a subset of the tetraspan transmembrane protein-encoding superfamily . LHFPL1 is also known as LHFPL tetraspan subfamily member 1 .
LHFPL1, located on chromosome X, has several aliases and external identifiers :
Aliases: LHFPL1, lipoma HMGIC fusion partner-like 1, lipoma HMGIC fusion partner like 1, and LHFPL tetraspan subfamily member 1
LHFPL1 belongs to the superfamily of tetraspan transmembrane proteins . It may regulate endothelial cell migration and tube formation and participate in assembling endothelial cell-cell junctions .
LHFPL1 is expressed in the ER of various tissues, particularly in the lung, thymus, skeletal muscle, colon, and ovary .
Predicted functional partners of LHFPL1 include :
AMOT (Angiomotin)
RTL4 (Retrotransposon Gag-like protein 4)
LRCH2 (Leucine-rich repeat and calponin homology domain-containing protein 2)
UBE4B (Ubiquitin conjugation factor E4 B)
ALG13 (Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13)
LRRK1 (Leucine-rich repeat kinase 1)
TRPC5 (Short transient receptor potential channel 5)
HTR2C (5-hydroxytryptamine receptor 2C)
ANKRD40 (Ankyrin repeat domain 40)
ATRX (Transcriptional regulator ATRX)
These proteins interact with LHFPL1 and participate in various cellular processes, including tight junction maintenance, cognitive function, cytoskeleton organization, and transcriptional regulation .
Mutations in LHFP-like genes can cause deafness in humans and mice . Additionally, one LHFP-like gene can fuse with a high-mobility group gene in translocation-associated lipomas .
Many antibodies target LHFPL1, which are used in various research applications :
| Antibody Provider | Catalog Number | Antibody Type | Application(s) |
|---|---|---|---|
| Cusabio Biotech Co., Ltd | CSB-PA774822LA01HU | Polyclonal | ELISA, ICC, IHC |
| antibodies-online | ABIN2489259 | Polyclonal | WB, IHC |
| Abgent | AP13197a | Polyclonal | WB |
| LSBio | LS-C160046 | Polyclonal | WB |
| Novus Biologicals | NBP1-91202 | Polyclonal | IHC |
LHFPL1 (Lipoma HMGIC Fusion Partner-Like 1) belongs to the LHFP gene family, which is a subset of the superfamily of tetraspan transmembrane protein encoding genes. The gene was mapped to Xq23 on the X chromosome in humans . In mice, the ortholog is located on the X chromosome as well .
LHFPL1 contains an open reading frame of 660 bp, encoding a protein with a signal peptide sequence and three transmembrane regions. The predicted molecular weight is approximately 23.7 kDa, which has been confirmed through prokaryotic expression systems .
The LHFP gene family was first discovered during research on lipomas (benign fatty tumors). The original LHFP gene was isolated as a novel translocation partner of the HMGIC gene (now known as HMGA2) in a lipoma with t(12;13) translocation .
In the lipoma studied, the expressed HMGIC/LHFP fusion transcript encoded the three DNA binding domains of HMGIC followed by 69 amino acids encoded by frame-shifted LHFP sequences . This discovery established LHFP as the second identified translocation partner of HMGIC in lipomas and represented a candidate target gene for lipomas with 13q aberrations.
LHFPL1 demonstrates widespread expression across multiple human tissues. RT-PCR amplification studies have revealed that LHFPL1 is expressed in all seventeen tested human tissues, with particularly high expression levels in:
| Tissue Type | Relative Expression Level |
|---|---|
| Lung | High |
| Thymus | High |
| Skeletal Muscle | High |
| Colon | High |
| Ovary | High |
| Other tissues | Moderate to low |
Additionally, LHFPL1 is transcribed in six liver tumor cell lines, suggesting potential roles in both normal and pathological tissue contexts .
LHFPL1 encodes a protein with three transmembrane domains and a signal peptide sequence . The protein is postulated to be localized to the endoplasmic reticulum. This structural arrangement suggests LHFPL1 may function in:
Membrane signaling processes
Cell-cell communication
Transport of molecules across membranes
Maintenance of cellular architecture
While the precise function remains to be fully elucidated, its structural characteristics provide important clues about its potential cellular roles .
Successful expression and purification of recombinant LHFPL1 requires careful consideration of several factors:
Expression Systems:
E. coli expression systems have been successfully used for LHFPL1 production . These provide high yields but may present challenges for proper folding of transmembrane domains.
Mammalian expression systems might be preferable for studying post-translational modifications and proper protein folding.
Purification Strategy:
For E. coli-expressed LHFPL1:
Inclusion body isolation followed by refolding
Detergent solubilization for membrane protein extraction
Affinity chromatography using histidine or other fusion tags
For mammalian-expressed LHFPL1:
Gentle membrane solubilization using appropriate detergents
Immunoprecipitation approaches
Size exclusion chromatography
When expressing transmembrane proteins like LHFPL1, careful optimization of detergent types and concentrations is critical for maintaining native conformation and function .
The LHFP gene family is directly linked to tumor biology through its relationship with HMGIC (HMGA2), particularly in lipomas:
Translocation Mechanisms: In lipomas with t(12;13) translocations, the LHFP gene acts as a fusion partner with HMGIC . This results in a fusion protein containing the DNA binding domains of HMGIC fused to partial LHFP sequences.
Functional Consequences: The HMGIC/LHFP fusion protein likely disrupts normal HMGIC function. HMGIC proteins are architectural transcription factors that regulate the expression of numerous genes through protein-DNA and protein-protein interactions .
Gene Expression Impact: The fusion event may alter target gene expression patterns, contributing to neoplastic transformation. HMGA proteins influence a diverse array of biological processes including cell growth, proliferation, differentiation, and death .
This relationship suggests LHFPL1 and related family members might play roles in tumor development through similar mechanisms, although direct evidence for LHFPL1's involvement is still being investigated .
The LHFPL family comprises several members with structural similarities but potentially diverse functions:
| Family Member | Chromosomal Location | Key Features | Associated Conditions |
|---|---|---|---|
| LHFP | 13q (human) | Original family member | Lipomas with t(12;13) |
| LHFPL1 | Xq23 (human) | 3 transmembrane domains | Under investigation |
| LHFPL2 | Multiple variants | LHFP-like protein 2 | Various potential roles |
| LHFPL3 | 7q22.2-q22.3 | 4 exons | Associated with obesity, cognitive performance traits |
| LHFPL4 | (partial gene fragment) | Corresponds to portion of LHFPL3 | Limited information |
Notably, mutations in some LHFPL-like genes result in deafness in humans and mice, suggesting potential roles in auditory function . LHFPL family members appear to be part of a larger tetraspan transmembrane protein superfamily with diverse biological functions .
Several methodological approaches have proven valuable for investigating LHFPL1:
Gene Expression Analysis:
Protein Characterization:
Cellular Localization:
Functional Studies:
Gene knockdown/knockout approaches
Overexpression studies
Protein-protein interaction analyses
Genomic Analysis:
These approaches can be combined to build a comprehensive understanding of LHFPL1 biology .
Recent research suggests potential roles for LHFPL1 in developmental processes:
HMGA proteins, which interact with LHFP family members, are hardly detectable in normal adult tissue but are abundantly expressed during embryonic development, suggesting potential developmental roles for their interaction partners .
In a study examining tetrabromobisphenol A (TBBPA) effects on differentiating mouse embryonic cells, Lhfpl1 was identified among genes consistently differentially expressed across multiple time points and concentration conditions .
LHFPL1's widespread tissue expression pattern, particularly in developmental contexts, suggests potential roles in tissue differentiation and organizational processes .
The membrane-spanning nature of LHFPL1 positions it as a candidate for cell-cell communication processes that are critical during development .
While direct functional evidence is still emerging, these observations point to potential developmental roles worthy of further investigation .
Several significant challenges exist in LHFPL1 research:
Structural Complexity: As a transmembrane protein, LHFPL1 presents challenges for structural characterization using traditional methods. Advanced approaches like cryo-electron microscopy may provide new insights into its three-dimensional organization.
Functional Ambiguity: Despite genomic and expression data, the precise cellular functions of LHFPL1 remain largely undefined. Systematic functional screening approaches are needed.
Relevance to Human Disease: While other LHFPL family members have clear disease associations, LHFPL1's role in human pathologies requires further investigation.
Future research directions should focus on:
Generating comprehensive interactome maps for LHFPL1
Developing tissue-specific and inducible knockout models
Investigating potential roles in developmental disorders and cancer biology
Exploring LHFPL1 as a potential therapeutic target or biomarker
Comparative analysis across species to understand evolutionary conservation of function
Addressing these challenges will require multidisciplinary approaches combining molecular biology, genetics, structural biology, and bioinformatics techniques .